IMC-A12
Jump to navigation
Jump to search
| IMC-A12 | |
|---|---|
| Term | IMC-A12 |
| Short definition | IMC-A12 - A substance being studied for the treatment of some types of cancer. It is a monoclonal antibody made in the laboratory that can bind to substances in the body. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
IMC-A12 - A substance being studied for the treatment of some types of cancer. It is a monoclonal antibody made in the laboratory that can bind to substances in the body. IMC-A12 blocks the action of a protein needed for cell growth and can kill cancer cells. It is a type of insulin-like growth factor 1 receptor (IGF-1R) inhibitor. Also called cixutumumab
External links
- Medical encyclopedia article on IMC-A12
- Wikipedia's article - IMC-A12
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski